A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Clinical trial NCT05562466 · RECRUITING
Trial details
- NCT number
- NCT05562466
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2028-02-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.